JP2023547405A5 - - Google Patents
Info
- Publication number
- JP2023547405A5 JP2023547405A5 JP2023524767A JP2023524767A JP2023547405A5 JP 2023547405 A5 JP2023547405 A5 JP 2023547405A5 JP 2023524767 A JP2023524767 A JP 2023524767A JP 2023524767 A JP2023524767 A JP 2023524767A JP 2023547405 A5 JP2023547405 A5 JP 2023547405A5
- Authority
- JP
- Japan
- Prior art keywords
- synthetic peptide
- peptide shuttle
- residues
- hydrophobic
- gnsn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063104340P | 2020-10-22 | 2020-10-22 | |
| US63/104,340 | 2020-10-22 | ||
| PCT/CA2021/051490 WO2022082315A1 (en) | 2020-10-22 | 2021-10-22 | Shuttle agent peptides of minimal lengh and variants thereof adapted for transduction of cas9-rnp and other nucleoprotein cargos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547405A JP2023547405A (ja) | 2023-11-10 |
| JP2023547405A5 true JP2023547405A5 (https=) | 2024-10-31 |
Family
ID=81291096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524767A Pending JP2023547405A (ja) | 2020-10-22 | 2021-10-22 | Ｃａｓ９－ＲＮＰ及び他の核タンパク質カーゴの形質導入のために適合された最小長のシャトル剤ペプチド及びそのバリアント |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230399661A1 (https=) |
| EP (1) | EP4232590A4 (https=) |
| JP (1) | JP2023547405A (https=) |
| KR (1) | KR20230088828A (https=) |
| CN (1) | CN116615227A (https=) |
| AU (1) | AU2021366976A1 (https=) |
| CA (1) | CA3196066A1 (https=) |
| IL (1) | IL302227A (https=) |
| WO (1) | WO2022082315A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110291100B (zh) | 2016-10-12 | 2024-06-11 | 费尔丹生物公司 | 用于将多肽负荷从细胞外空间递送至靶真核细胞的胞质溶胶和/或细胞核的合理设计的合成肽穿梭剂，其用途、与其相关的方法和试剂盒 |
| CA3040645A1 (en) | 2019-04-18 | 2020-10-18 | Feldan Bio Inc. | Peptide-based non-proteinaceous cargo delivery |
| WO2024206311A1 (en) * | 2023-03-31 | 2024-10-03 | The Trustees Of The University Of Pennsylvania | Hybrid antimicrobial peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2981716C (en) * | 2015-04-10 | 2022-04-12 | Feldan Bio Inc. | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same |
| CN110291100B (zh) * | 2016-10-12 | 2024-06-11 | 费尔丹生物公司 | 用于将多肽负荷从细胞外空间递送至靶真核细胞的胞质溶胶和/或细胞核的合理设计的合成肽穿梭剂，其用途、与其相关的方法和试剂盒 |
| CA3040645A1 (en) * | 2019-04-18 | 2020-10-18 | Feldan Bio Inc. | Peptide-based non-proteinaceous cargo delivery |
-
2021
- 2021-10-22 AU AU2021366976A patent/AU2021366976A1/en active Pending
- 2021-10-22 CN CN202180085398.1A patent/CN116615227A/zh active Pending
- 2021-10-22 EP EP21881421.8A patent/EP4232590A4/en active Pending
- 2021-10-22 CA CA3196066A patent/CA3196066A1/en active Pending
- 2021-10-22 WO PCT/CA2021/051490 patent/WO2022082315A1/en not_active Ceased
- 2021-10-22 IL IL302227A patent/IL302227A/en unknown
- 2021-10-22 US US18/033,280 patent/US20230399661A1/en active Pending
- 2021-10-22 JP JP2023524767A patent/JP2023547405A/ja active Pending
- 2021-10-22 KR KR1020237017143A patent/KR20230088828A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547405A5 (https=) | ||
| JP2019531316A5 (https=) | ||
| JP6698756B2 (ja) | 細胞に分子を送達する方法及び担体複合体 | |
| JP5837542B2 (ja) | ミトコンドリア透過性転移の阻止方法 | |
| Martin et al. | Peptide-guided gene delivery | |
| JP2018512891A5 (https=) | ||
| JP2010536714A5 (https=) | ||
| RU2012106150A (ru) | Вариантные формы уратоксидазы и их применение | |
| CN101815535A (zh) | 用于使化合物靶向多种选定器官或组织的分子 | |
| JP2021531248A5 (https=) | ||
| KR20190104021A (ko) | 다양하게 선택된 기관 또는 조직을 표적화하기 위한 물질 | |
| AR068020A1 (es) | Terapia combinada para el cancer de pancreas usando un peptido antigenico y un agente quimioterapeutico | |
| JP2023511501A5 (https=) | ||
| US10632187B2 (en) | Hemagglutinin-binding peptide | |
| CA2837445C (en) | Therapeutic agents for regulating serum phosphorus | |
| WO2023027125A1 (ja) | ヒトトランスフェリンレセプター結合抗体－ペプチドコンジュゲート | |
| AU2012267470A1 (en) | Therapeutic agents for regulating serum phosphorus | |
| JP2013501030A (ja) | 新規抗病原性ペプチド | |
| US20020111305A1 (en) | Antiviral peptides | |
| JP2013071904A (ja) | 抗インフルエンザウイルス活性を有するペプチド | |
| CN109310729B (zh) | 用于改善转染效率的合成化合物 | |
| JP2022506044A5 (https=) | ||
| CN119421888A (zh) | 具有抗微生物活性的哺乳动物乳源肽 | |
| JP2009503092A5 (https=) | ||
| JP2019522041A (ja) | 新規のペプチド及びペプチド模倣体 |